In a striking revelation, recent research indicates that over three million children tragically lost their lives in 2022 due to infections resistant to antibiotics. This study, conducted by top specialists in child health, highlights that the highest rates of antimicrobial resistance (AMR) are concentrated in Africa and South East Asia.
AMR occurs when bacteria adapt to antibiotic treatments, rendering them ineffective, and has emerged as one of the most pressing threats to global health. The authors of the report, which utilized data from the World Health Organization (WHO) and the World Bank, situated the child fatalities at more than three million, a figure that illustrates the severity of AMR's toll on health outcomes for children.
A concerning surge in AMR-related infections affecting children has been noted, with a more than tenfold increase over the past three years. The ongoing COVID-19 pandemic may have exacerbated this situation, due in part to increased antibiotic usage during health crises.
Antibiotics are indeed vital for treating numerous bacterial infections, including serious conditions like pneumonia, yet they do not treat viral infections. The excessive and often inappropriate use of antibiotics has led to the evolution of resistant bacteria, while the development of new antibiotics—which is inherently slow and costly—has stalled.
Dr. Yanhong Jessika Hu from Murdoch Children's Research Institute and Prof. Herb Harwell from the Clinton Health Access Initiative led the study, revealing alarming statistics about antibiotic use in vulnerable regions. The usage of "watch antibiotics" surged by 160% in South East Asia and 126% in Africa between 2019 and 2021, while "reserve antibiotics" rose significantly as well.
As more bacteria gain resistance, the authors warn that the medical community faces dwindling options for treating severe infections. Prof. Harwell emphasized the global scale of AMR, particularly how it disproportionately impacts children. He stated, "We estimate three million deaths of children worldwide associated with antimicrobial resistance."
The WHO classifies AMR as a grave global health threat, yet solutions remain elusive. Prof. Harwell noted that addressing AMR is complex, necessitating improved hygiene, sanitation, and immunization to prevent infections. Dr. Lindsey Edwards from King’s College London echoed these sentiments, asserting that the findings should prompt immediate action from global health authorities to avert a regression in child health progress.
As the world grapples with the repercussions of AMR, decisive measures are critical to safeguard vulnerable populations, particularly children who bear the brunt of this burgeoning health crisis.
